Compare PSTV & OFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PSTV | OFS |
|---|---|---|
| Founded | 1996 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 80.4M | 67.1M |
| IPO Year | N/A | 2012 |
| Metric | PSTV | OFS |
|---|---|---|
| Price | $0.24 | $4.66 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $6.75 | N/A |
| AVG Volume (30 Days) | ★ 18.2M | 63.5K |
| Earning Date | 10-30-2025 | 03-02-2026 |
| Dividend Yield | N/A | ★ 13.68% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.24 |
| Revenue | $5,258,000.00 | ★ $42,970,000.00 |
| Revenue This Year | $1.73 | N/A |
| Revenue Next Year | $12.05 | N/A |
| P/E Ratio | ★ N/A | $20.62 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.16 | $4.44 |
| 52 Week High | $2.31 | $9.80 |
| Indicator | PSTV | OFS |
|---|---|---|
| Relative Strength Index (RSI) | 25.75 | 42.87 |
| Support Level | $0.22 | $4.91 |
| Resistance Level | $0.25 | $5.01 |
| Average True Range (ATR) | 0.03 | 0.22 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 10.34 | 6.45 |
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).
OFS Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its business objective is to generate current income and capital appreciation by investing in middle-market companies in the United States. The company focuses on investments in senior secured loans, including first lien, second lien, and unitranche loans, as well as subordinated loans and, to a lesser extent, warrants, and other equity securities.